CRNX- Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. (CRNX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 223.2K | $18.73M | - | |
| Other | 147.7K | $12.40M | - | |
| COO | 121.9K | $10.23M | - | |
| CFO | 84.8K | $7.12M | - | |
| Other | 69.0K | $5.79M | - |
Activity
Buys and sells only
Transactions
10 filings · page 5
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Struthers Richard Scott54 | President &CEO | Sale+OE | 40,951 | $49.17 | $2,013,560.67 | -14.7% | -5.3% | -42.4% | |
| Mar 28, 2024 | Okey Stephanie56 | Director | Sale+OE | 17,500 | $46.38 | $811,650.00 | -74.5% | -9.9% | -25.8% | |
| Mar 22, 2024 | Knight Jeff E.68 | Chief Operating Officer | Sale+OE | 32,359 | $44.31 | $1,433,675.01 | -23.1% | -0.2% | -22.3% | |
| Mar 20, 2024 | Fust Matthew K77 | Director | Sale+OE | 60,000 | $44.14 | $2,648,150.00 | -44.7% | -2.6% | -24.5% | |
| Mar 20, 2024 | Pizzuti Dana56 | Chief Med And Dev Officer | Sale+OE | 15,089 | $44.06 | $664,763.41 | -15.1% | -2.6% | -24.5% | |
| Mar 19, 2024 | Wilson Marc53 | CFO | Sell | 6,942 | $42.91 | $297,881.22 | -5.9% | -1.0% | -23.3% | |
| Jan 25, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $37.26 | $111,780.00 | -3.9% | +16.3% | +4.1% | |
| Jan 10, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $37.65 | $112,950.00 | -3.8% | +24.8% | +8.0% | |
| Jan 3, 2024 | Pizzuti Dana56 | Chief Med And Dev Officer | Sale+OE | 14,375 | $35.00 | $503,125.00 | -70.9% | +31.6% | +47.5% | |
| Jan 2, 2024 | Wilson Marc53 | CFO | Sale+OE | 10,000 | $35.47 | $354,700.00 | -9.4% | +31.5% | +45.7% |